Intuit Earnings Report Could Test Morgan Stanleys Stock Forecast MLS Cup Shift to Memorial Day Could Boost League Revenue and Viewership Wholesale Inflation Accelerates Producer Price Index Surges 6 Annually in April Largest Gain Since 2022 SP 500 Inches Higher as Healthcare and Tech Lead Communication Services Slips Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut with Broader Product Ambitions Possible FirstDay Valuations for SpaceX OpenAI and Anthropic Could Surpass Berkshire Hathaway According to Polymarket Traders BKD Q1 2026 Earnings EPS Misses Estimates by 35 as Senior Housing Operator Faces Headwinds PONY Q1 2026 Earnings Narrower Loss Per ADS Drives Positive Investor Sentiment LOCO Q1 2026 Earnings EPS Surges Past Estimates by 276 Shares Dip Slightly AGI Q1 2026 Earnings EPS Misses Estimates Stock Declines on Profitability Concerns FRPH Q4 2024 Earnings EPS of 009 Reported Stock Declines Slightly ACI Q1 2026 Earnings EPS Beats Estimates by 1034 as Grocer Shows Resilience NeOnc Technologies Holds Ground Near Key Support Amid Biotech Uncertainty NTHI VICI Properties VICI Holds Steady Near 2850 as REIT Sector Weighs Macro Headwinds Offerpad Solutions Inc OPAD Bounces 4 as Stock Holds Near Key Support Oxford Square Capital OXSQ Surges 78 Breaking Past Key Support Level Senti Biosciences Edges Higher Near Key Resistance Level Amgen Announces CFO Peter Griffiths Retirement Succession Planning Underway NEU Q1 2026 Earnings Strong EPS Performance Amidst Operational Stability Insight Digital Partners II DYOR Edges Higher Near Resistance on Minimal Price Action HSIC Q1 2026 Earnings EPS Beat of 631 Surprises Analysts FLOC Q1 2026 Earnings Massive EPS Beat But Stock Declines SFL Q1 2026 Earnings Stunning EPS Surprise of 1880 Despite Negative Stock Reaction TSAT Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Amid Revenue Disclosures Still Pending BHP Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Commodity Conditions JMSB Q1 2026 Earnings EPS Beats Estimates Stock Rises 123 Outlook Therapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Surges 29